RISK FACTORS FOR NON-ADHERENCE TO BIOLOGIC THERAPIES IN INFLAMMATORY BOWEL DISEASE

被引：1
|
作者：
Wentworth, Brian J.
Buerlein, Ross C. D.
Nakamura, Takahiro
Tuskey, Anne G.
Overby, M. Ashely
Smolkin, Mark E.
Behm, Brian W.
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2018年 / 24卷
关键词：
D O I：
10.1093/ibd/izy037.030
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P158
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [41] Identifying risk factors for medication non-adherence
    Oldenquist, G
    Fried, L
    Rubin, G
    Xue, Q
    Carlson, M
    [J]. GERONTOLOGIST, 2002, 42 : 142 - 143
  • [42] RISK FACTORS FOR ANTIHYPERTENSIVE MEDICATION NON-ADHERENCE
    Hajjar, M. A.
    Ray, M. M.
    Tang, J.
    Wan, J. Y.
    Bailey, J. E.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 418 - 418
  • [43] Use of immunomodulators and biologic therapies in children with inflammatory bowel disease
    Bousvaros, Athos
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (04) : 659 - 666
  • [44] Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies
    Cozzi, Giacomo
    Scagnellato, Laura
    Lorenzin, Mariagrazia
    Savarino, Edoardo
    Zingone, Fabiana
    Ometto, Francesca
    Favero, Marta
    Doria, Andrea
    Vavricka, Stephan R.
    Ramonda, Roberta
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (08) : 503 - 518
  • [45] Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies
    Giacomo Cozzi
    Laura Scagnellato
    Mariagrazia Lorenzin
    Edoardo Savarino
    Fabiana Zingone
    Francesca Ometto
    Marta Favero
    Andrea Doria
    Stephan R. Vavricka
    Roberta Ramonda
    [J]. Nature Reviews Rheumatology, 2023, 19 : 503 - 518
  • [46] The impact of pregnancy on biologic therapies for the treatment of inflammatory bowel disease
    Picardo, Sherman
    Seow, Cynthia H.
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2020, 44-45
  • [47] Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
    Kim, Duk Hwan
    Cheon, Jae Hee
    [J]. IMMUNE NETWORK, 2017, 17 (01) : 25 - 40
  • [48] NON-ADHERENCE TO SELF-INJECTABLE BIOLOGIC MEDICATION IN PATIENTS WITH MODERATE TO SEVERE INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH INCREASED HEALTHCARE RESOURCE UTILIZATION
    Haydek, Jennifer
    Shah, Nisha
    Slaughter, James C.
    Ashton, Jonathan R.
    Wong, Rochelle
    Zuckerman, Autumn
    Duley, Caroline
    Garrett, Ailish
    Annis, Kim
    Wagnon, Julianne
    Dalal, Robin L.
    Scoville, Elizabeth A.
    Beaulieu, Dawn
    Schwartz, David A.
    Horst, Sara N.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S414 - S414
  • [49] Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease
    Roig, Clara Amiama
    Ferrer, Cristina Suarez
    Garcia, Jose Luis Rueda
    Cordon, Joaquin Poza
    Sanchez-Azofra, Maria
    Arranz, Eduardo Martin
    Diaz, Irene Gonzalez
    Costa, Carmen Amor
    Martin-Arranz, Maria Dolores
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (02): : 109 - 115
  • [50] Prevalence and factors associated with vitamin D deficiency in patients with inflammatory bowel disease on biologic therapies
    Sugrue, K.
    Fitzgerald, D.
    Buckley, M.
    McCarthy, J.
    Farrell, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S113 - S113
12345